The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Decade of insights: Bleomycin-induced pneumonitis and use of G-CSF in chemotherapy-treated germ cell testicular tumors and Hodgkin lymphoma—Real-world outcomes from an academic cancer center.
 
Manan Shah
No Relationships to Disclose
 
Amir Mortazavi
Consulting or Advisory Role - Targeted Oncology
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Seagen (Inst)
 
Edmund Folefac
No Relationships to Disclose
 
Peng Wang
No Relationships to Disclose
 
Katharine A. Collier
No Relationships to Disclose
 
Lingbin Meng
No Relationships to Disclose
 
Kelly Slavens
No Relationships to Disclose
 
Meghan Hinkley
No Relationships to Disclose
 
Paul Monk
Consulting or Advisory Role - Dendreon; Myovant Sciences; Pfizer/NCCN; Sanofi
Research Funding - Arvinas (Inst); Bayer (Inst); BioXCell (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); regeneron (Inst)
 
David Alan Bond
Consulting or Advisory Role - Novartis; Nurix; TG Therapeutics
Research Funding - Genmab (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Nurix (Inst)